Arjo Financial Statements From 2010 to 2025
| ARRJF Stock | USD 3.35 0.00 0.00% |
Check Arjo AB financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Arjo AB's main balance sheet or income statement drivers, such as , as well as many indicators such as . Arjo financial statements analysis is a perfect complement when working with Arjo AB Valuation or Volatility modules.
Arjo |
Arjo AB Company Shares Outstanding Analysis
Arjo AB's Outstanding Shares are shares of common stock of a public company that were purchased by investors after they were authorized and issued by the company to the public. Outstanding Shares are typically reported on fully diluted basis, including exotic instruments such as options, or convertibles bonds.
Current Arjo AB Shares Outstanding | 272.37 M |
Most of Arjo AB's fundamental indicators, such as Shares Outstanding, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Arjo AB is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Outstanding shares that are stated on company Balance Sheet are used when calculating many important valuation and performance indicators including Return on Equity, Market Cap, EPS and many others.
| Competition |
Based on the latest financial disclosure, Arjo AB has 272.37 M of shares currently outstending. This is 50.87% higher than that of the Healthcare sector and 80.18% higher than that of the Medical Distribution industry. The shares outstanding for all United States stocks is 52.37% higher than that of the company.
Arjo AB Fundamental Drivers Relationships
Comparative valuation techniques use various fundamental indicators to help in determining Arjo AB's current stock value. Our valuation model uses many indicators to compare Arjo AB value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Arjo AB competition to find correlations between indicators driving Arjo AB's intrinsic value. More Info.Arjo AB is rated third in return on equity category among its peers. It is rated second in return on asset category among its peers reporting about 0.54 of Return On Asset per Return On Equity. The ratio of Return On Equity to Return On Asset for Arjo AB is roughly 1.84 . The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Arjo AB's earnings, one of the primary drivers of an investment's value.About Arjo AB Financial Statements
Arjo AB stakeholders use historical fundamental indicators, such as Arjo AB's revenue or net income, to determine how well the company is positioned to perform in the future. Although Arjo AB investors may analyze each financial statement separately, they are all interrelated. For example, changes in Arjo AB's assets and liabilities are reflected in the revenues and expenses on Arjo AB's income statement, which ultimately affect the company's gains or losses. Understanding these patterns can help in making the right long-term investment decisions in Arjo AB. Please read more on our technical analysis and fundamental analysis pages.
Arjo AB develops and sells medical devices and solutions for patients with reduced mobility and age-related health challenges in North America, Western Europe, and internationally. The company was founded in 1957 and is headquartered in Malm, Sweden. Arjo Ab operates under Medical Distribution classification in the United States and is traded on OTC Exchange. It employs 6500 people.
Currently Active Assets on Macroaxis
| DD | Dupont De Nemours | |
| CRDO | Credo Technology Group | |
| GOOG | Alphabet Inc Class C | |
| BAC | Bank of America | |
| CRM | Salesforce |
Other Information on Investing in Arjo Pink Sheet
Arjo AB financial ratios help investors to determine whether Arjo Pink Sheet is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Arjo with respect to the benefits of owning Arjo AB security.